Oculis locks in $57m Series C
Oculis, a developer of ophthalmic treatments, has raised $57 million in Series C financing.
Oculis, a developer of ophthalmic treatments, has raised $57 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination